ATE230737T1 - Aminsäure-salzverbindungen und ein verfahren zu ihrer herstellung - Google Patents
Aminsäure-salzverbindungen und ein verfahren zu ihrer herstellungInfo
- Publication number
- ATE230737T1 ATE230737T1 AT96927432T AT96927432T ATE230737T1 AT E230737 T1 ATE230737 T1 AT E230737T1 AT 96927432 T AT96927432 T AT 96927432T AT 96927432 T AT96927432 T AT 96927432T AT E230737 T1 ATE230737 T1 AT E230737T1
- Authority
- AT
- Austria
- Prior art keywords
- acid salt
- production
- amino acid
- salt compounds
- acid
- Prior art date
Links
- -1 AMINO ACID SALT COMPOUNDS Chemical class 0.000 title abstract 2
- 239000002253 acid Substances 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 2
- 238000006276 transfer reaction Methods 0.000 abstract 2
- 150000001412 amines Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/68—Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/12—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/515,790 US5686588A (en) | 1995-08-16 | 1995-08-16 | Amine acid salt compounds and process for the production thereof |
| PCT/US1996/013246 WO1997007112A1 (en) | 1995-08-16 | 1996-08-16 | Amine acid salt compounds and process for the production thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE230737T1 true ATE230737T1 (de) | 2003-01-15 |
Family
ID=24052741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96927432T ATE230737T1 (de) | 1995-08-16 | 1996-08-16 | Aminsäure-salzverbindungen und ein verfahren zu ihrer herstellung |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5686588A (de) |
| EP (1) | EP0859768B1 (de) |
| JP (1) | JPH11508601A (de) |
| KR (1) | KR100259205B1 (de) |
| CN (1) | CN100338050C (de) |
| AT (1) | ATE230737T1 (de) |
| AU (1) | AU713507B2 (de) |
| BR (1) | BR9610288A (de) |
| CA (1) | CA2227264C (de) |
| DE (1) | DE69625699T2 (de) |
| IL (1) | IL123212A0 (de) |
| MX (1) | MX9801205A (de) |
| WO (1) | WO1997007112A1 (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5973005A (en) * | 1998-02-26 | 1999-10-26 | Bio-Bontanica, Inc. | Aqueous creatine solution and process of producing a stable, bioavailable aqueous creatine solution |
| US7772220B2 (en) * | 2004-10-15 | 2010-08-10 | Seo Hong Yoo | Methods and compositions for reducing toxicity of a pharmaceutical compound |
| US6251428B1 (en) | 1998-07-24 | 2001-06-26 | Seo Hong Yoo | Preparation of aqueous clear solution dosage forms with bile acids |
| US20050158408A1 (en) * | 1998-07-24 | 2005-07-21 | Yoo Seo H. | Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof |
| US7303768B2 (en) * | 1998-07-24 | 2007-12-04 | Seo Hong Yoo | Preparation of aqueous clear solution dosage forms with bile acids |
| US6316020B1 (en) | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
| US6369087B1 (en) | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| US6268385B1 (en) | 1999-08-26 | 2001-07-31 | Robert R. Whittle | Dry blend pharmaceutical formulations |
| US6312712B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Method of improving bioavailability |
| US6326384B1 (en) | 1999-08-26 | 2001-12-04 | Robert R. Whittle | Dry blend pharmaceutical unit dosage form |
| US6262085B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| US6780880B1 (en) | 1999-08-26 | 2004-08-24 | Robert R. Whittle | FT-Raman spectroscopic measurement |
| US6312723B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Pharmaceutical unit dosage form |
| US6262086B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Pharmaceutical unit dosage form |
| CA2406930C (en) * | 2000-02-04 | 2011-02-15 | Seo Hong Yoo | Preparation of aqueous clear solution dosage forms with bile acids |
| US7145125B2 (en) | 2003-06-23 | 2006-12-05 | Advanced Optical Technologies, Llc | Integrating chamber cone light using LED sources |
| KR101414810B1 (ko) * | 2004-08-30 | 2014-07-18 | 주식회사 유스팜인터내셔널 | 국소 허혈 모델에서의 가용화 ｕｄｃａ의 신경보호 효과 |
| DE602005027727D1 (de) * | 2004-10-15 | 2011-06-09 | Seo Hong Yoo | Zusammensetzungen zur verringerung der toxizität von cisplatin, carboplatin und oxaliplatin |
| JP2008518935A (ja) * | 2004-11-01 | 2008-06-05 | セオ ホン ユー | 筋萎縮性側索硬化症の神経退行を減少させるための方法及び組成物 |
| US20060160783A1 (en) * | 2004-12-30 | 2006-07-20 | Transform Pharmaceuticals, Inc. | Novel omeprazole forms and related methods |
| WO2006109324A2 (en) * | 2005-04-13 | 2006-10-19 | Lupin Limited | Processes for preparation of amorphous cefepime acid addition salts |
| ITMI20051684A1 (it) * | 2005-09-13 | 2007-03-14 | Harvest Lodge Ltd | Procedimento per la produzione del dicloridrato di amminoacidi |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4107424A (en) * | 1972-10-06 | 1978-08-15 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | 1-N-[(S)-α-hydroxy-ω-aminoacyl] derivatives of 3',4'-dideoxykanamycin B and 3'-deoxykanamycin B antibiotics |
| GB1565966A (en) * | 1976-08-04 | 1980-04-23 | Allen & Hanburys Ltd | Aminoalkyl furan derivatives |
| SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
| CH654830A5 (en) * | 1980-01-08 | 1986-03-14 | Glaxo Group Ltd | Aziridine derivative |
| CA1171096A (en) * | 1980-01-08 | 1984-07-17 | Glaxo Group Limited | Process for the preparation of a furan derivative |
| IL63968A (en) * | 1980-10-01 | 1985-10-31 | Glaxo Group Ltd | Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it |
| ES8307236A1 (es) * | 1981-02-20 | 1983-02-01 | Glaxo Group Ltd | Un procedimiento para la preparacion de ranitidina. |
| US4406899A (en) * | 1982-03-04 | 1983-09-27 | Bristol-Myers Company | Cephalosporins |
| GB8415254D0 (en) * | 1984-06-15 | 1984-07-18 | Glaxo Group Ltd | Amine derivatives |
| GB8907700D0 (en) * | 1989-04-05 | 1989-05-17 | Fine Organics Ltd | Preparation of substituted ethenes |
| GB9009240D0 (en) * | 1990-04-25 | 1990-06-20 | Glaxo Group Ltd | Chemical compounds |
| US5338871A (en) * | 1991-12-20 | 1994-08-16 | Torcan Chemical Ltd. | Preparation of form 1 ranitidine hydrochloride |
-
1995
- 1995-08-16 US US08/515,790 patent/US5686588A/en not_active Expired - Lifetime
-
1996
- 1996-08-16 WO PCT/US1996/013246 patent/WO1997007112A1/en active IP Right Grant
- 1996-08-16 BR BR9610288A patent/BR9610288A/pt unknown
- 1996-08-16 MX MX9801205A patent/MX9801205A/es unknown
- 1996-08-16 CN CNB961973366A patent/CN100338050C/zh not_active Expired - Fee Related
- 1996-08-16 IL IL12321296A patent/IL123212A0/xx unknown
- 1996-08-16 EP EP96927432A patent/EP0859768B1/de not_active Expired - Lifetime
- 1996-08-16 AU AU67255/96A patent/AU713507B2/en not_active Ceased
- 1996-08-16 CA CA002227264A patent/CA2227264C/en not_active Expired - Fee Related
- 1996-08-16 DE DE69625699T patent/DE69625699T2/de not_active Expired - Lifetime
- 1996-08-16 AT AT96927432T patent/ATE230737T1/de not_active IP Right Cessation
- 1996-08-16 JP JP9509483A patent/JPH11508601A/ja active Pending
- 1996-08-16 KR KR1019980701114A patent/KR100259205B1/ko not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997007112A1 (en) | 1997-02-27 |
| IL123212A0 (en) | 1998-09-24 |
| CA2227264C (en) | 2002-10-22 |
| MX9801205A (es) | 1998-04-30 |
| CN1198744A (zh) | 1998-11-11 |
| EP0859768A4 (de) | 1998-11-11 |
| DE69625699T2 (de) | 2003-11-06 |
| KR100259205B1 (ko) | 2000-07-01 |
| KR19990037637A (ko) | 1999-05-25 |
| CN100338050C (zh) | 2007-09-19 |
| AU713507B2 (en) | 1999-12-02 |
| CA2227264A1 (en) | 1997-02-27 |
| JPH11508601A (ja) | 1999-07-27 |
| EP0859768B1 (de) | 2003-01-08 |
| BR9610288A (pt) | 1999-07-27 |
| DE69625699D1 (de) | 2003-02-13 |
| EP0859768A1 (de) | 1998-08-26 |
| US5686588A (en) | 1997-11-11 |
| AU6725596A (en) | 1997-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE230737T1 (de) | Aminsäure-salzverbindungen und ein verfahren zu ihrer herstellung | |
| ES8801920A1 (es) | Procedimiento para la obtencio de enaminas | |
| ATE101116T1 (de) | Gabapentinmonohydrat und verfahren zu dessen herstellung. | |
| AU2507088A (en) | Amino acid derivatives of phosphorus acids | |
| PL266567A1 (en) | A method of crystalline acid hydrates 7-2-/2-aminotiazolil-4/4-carboxylobutene-2-oiloamino-3-cefemocarboxyl-4 production | |
| DE69704561T2 (de) | Stabile nicht-hygroskopische salze von l(-)carnitin und alkanoyl-l(-)carnitinen,ein verfahren zu deren herstellung und feste, oral verabreichbare zusammensetzungen, die solche salze enthalten | |
| PT79411A (en) | Process for preparing a novel anhydrous stable crystalline delta-form of prazosina hydrochloride | |
| AU8711791A (en) | Process for producing salt of amino carboxylic acid | |
| AU1892988A (en) | Hydroxyalkyl-azolyl derivatives | |
| CA2080221A1 (en) | An improved process for the preparation of substituted indolone derivatives | |
| HUT49360A (en) | Process for producing n-(phosphonomethyl)-iminodiacetic acid from the double salt of iminodiacetic acid | |
| HUT45518A (en) | Process for producing 1,5-benzothiazepine derivatives and pharmaceutics comprising these compounds | |
| AU2038988A (en) | A process for the manufacture of novel unsaturated amino acid compounds | |
| CA2282381A1 (en) | Process for the preparation of nicotinic acids | |
| ATE457300T1 (de) | Dikarbonsäuresalze des acetyl-l-carnitins und verfahren zu ihrer herstellung | |
| ATE171936T1 (de) | Salpetersäureester von 2-(2,6-dihalophenylamino) phenylacetoessigsäurederivaten und verfahren zu ihrer herstellung | |
| EP0708753A4 (de) | Synthese von säureadditionssalzen von hydroxylaminen | |
| KR860004838A (ko) | 결정상태의 글루타민산을 제조하는 방법 | |
| ES8601099A1 (es) | Procedimiento para la preparacion de nuevos derivados de n-(metoxifenacil)-amina | |
| AT400030B (de) | Verfahren zur herstellung von 1-alkylamino-2-nitroethen-1-thiolderivaten | |
| CA2277151A1 (en) | Synthesis of acyclic nucleoside derivatives | |
| MY110724A (en) | Process for converting loracarbef dihydrate to loracarbef monohydrate | |
| TW370520B (en) | A process for the preparation of NG-monomethyl-L-arginine hydrochloride | |
| TH44062EX (th) | กรรมวิธีสำหรับเปลี่ยนโลราคาร์เบฟ ไดไฮเดรท ไปเป็น โลราคาร์เบฟ มอนอไฮเดรท | |
| PT86498A (en) | A method for the production of crystalline amino-protected-beta-benzyl-l-aspartic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |